• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌检测算法:什么是切实可行的?

Clostridium difficile testing algorithms: what is practical and feasible?

机构信息

Clinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals, Chapel Hill, NC 27514, USA.

出版信息

Anaerobe. 2009 Dec;15(6):270-3. doi: 10.1016/j.anaerobe.2009.10.005. Epub 2009 Oct 22.

DOI:10.1016/j.anaerobe.2009.10.005
PMID:19853666
Abstract

There has been renewed interest in the laboratory diagnosis of Clostridium difficile infections due in large measure to the increase in both numbers and severity of cases of this disease. For the past two decades, enzyme-immunoassays (EIAs) for the detection of first C. difficile toxin A and then toxins A and B have been the most widely used diagnostic test for diagnosis of C. difficile infections. Recently this diagnostic approach has been called into question by the recognition that a screening test which detects glutamate dehydrogenase, a cell wall antigen of C. difficile, was significantly more sensitive than toxins A and B EIAs making it an effective screening test for C. difficile infection. Although sensitive, GDH lacks specificity and so if this test was utilized, a confirmatory test to differentiate false positives from true positives was needed. Studies to date have used cytotoxin neutralization or toxigenic culture as confirmatory tests but both of these have their limitations. A testing algorithm using rapid immunochromatographic devices for detection of GDH and toxins A and B as screening tests will give an accurate test result in approximately 90% of specimens within one hour when using cytotoxin neutralization as a reference method. For the other 10% of specimens, a third test would be needed in the algorithm. This test could be cytotoxin neutralization, toxigenic culture, or PCR for toxin or toxin operon genes.

摘要

由于这种疾病的病例数量和严重程度都在增加,人们对艰难梭菌感染的实验室诊断重新产生了兴趣。在过去的二十年中,用于检测第一种艰难梭菌毒素 A 然后是毒素 A 和 B 的酶免疫测定(EIAs)一直是诊断艰难梭菌感染的最广泛使用的诊断测试。最近,人们认识到,一种检测谷氨酸脱氢酶(艰难梭菌细胞壁抗原)的筛选试验比毒素 A 和 B EIAs 灵敏得多,这使得它成为一种有效的艰难梭菌感染筛选试验,从而对这种诊断方法提出了质疑。尽管灵敏,但 GDH 缺乏特异性,因此如果使用该测试,则需要一种确认测试来区分假阳性和真阳性。迄今为止的研究已经使用细胞毒素中和或产毒培养作为确认测试,但这两种测试都有其局限性。使用快速免疫层析设备检测 GDH 和毒素 A 和 B 作为筛选测试的测试算法,当使用细胞毒素中和作为参考方法时,将在大约 90%的标本中在一小时内给出准确的测试结果。对于另外 10%的标本,算法中还需要进行第三种测试。该测试可以是细胞毒素中和、产毒培养或用于毒素或毒素操纵子基因的 PCR。

相似文献

1
Clostridium difficile testing algorithms: what is practical and feasible?艰难梭菌检测算法:什么是切实可行的?
Anaerobe. 2009 Dec;15(6):270-3. doi: 10.1016/j.anaerobe.2009.10.005. Epub 2009 Oct 22.
2
Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.两步谷氨酸脱氢酶抗原实时聚合酶链反应检测产毒艰难梭菌。
J Hosp Infect. 2010 Jan;74(1):48-54. doi: 10.1016/j.jhin.2009.08.014. Epub 2009 Nov 8.
3
Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.比较 VIDAS CDAB 和 CDA 免疫检测法在 tcdA- tcdB+ 艰难梭菌流行地区检测艰难梭菌的效果。
Anaerobe. 2009 Dec;15(6):266-9. doi: 10.1016/j.anaerobe.2009.09.008. Epub 2009 Sep 20.
4
Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.TechLab艰难梭菌快速检测试剂盒和TechLab艰难梭菌毒素A/B II检测试剂盒在粪便样本中检测艰难梭菌的性能。
Diagn Microbiol Infect Dis. 2007 Sep;59(1):33-7. doi: 10.1016/j.diagmicrobio.2007.04.018. Epub 2007 Jul 26.
5
Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.用于粪便样本中艰难梭菌快速检测的生物位点分诊艰难梭菌检测板评估。
J Clin Microbiol. 2001 May;39(5):1855-8. doi: 10.1128/JCM.39.5.1855-1858.2001.
6
Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.艰难梭菌相关性疾病的诊断:使用毒素酶免疫测定、谷氨酸脱氢酶酶免疫测定和环介导等温扩增对多种算法进行检测
Br J Biomed Sci. 2012;69(3):112-8.
7
Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.用于艰难梭菌腹泻诊断的分诊免疫测定、毒素A和B酶免疫测定以及细胞毒素B组织培养测定各组分的临床实用性。
Am J Clin Pathol. 2003 Jan;119(1):45-9. doi: 10.1309/U8AT-L52Q-60XY-AVX6.
8
Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.重新评估 Premier 艰难梭菌毒素 A 和 B 免疫测定法,并与谷氨酸脱氢酶共同抗原检测进行比较,评估 Bartels 细胞毒素和 Prodesse ProGastro Cd 聚合酶链反应作为确认程序。
Diagn Microbiol Infect Dis. 2010 Feb;66(2):129-34. doi: 10.1016/j.diagmicrobio.2009.09.001.
9
A simple 3-step algorithm for improved laboratory detection of Clostridium difficile toxin without the need for tissue culture cytotoxicity neutralization assays.一种简单的三步算法,用于改进艰难梭菌毒素的实验室检测,无需组织培养细胞毒性中和试验。
Diagn Microbiol Infect Dis. 2009 Jul;64(3):344-6. doi: 10.1016/j.diagmicrobio.2009.03.009. Epub 2009 Apr 18.
10
Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.TechLab艰难梭菌检测-60酶免疫测定法(EIA)联合艰难梭菌毒素A/B II EIA试剂盒、Triage艰难梭菌检测板免疫测定法及细胞毒素测定法用于诊断艰难梭菌相关性腹泻的性能
J Clin Microbiol. 2004 Oct;42(10):4863-5. doi: 10.1128/JCM.42.10.4863-4865.2004.

引用本文的文献

1
Comparative Evaluation of Three Immunoassays for the Simultaneous Detection of Glutamate Dehydrogenase and Toxin A/B.三种免疫分析法同时检测谷氨酸脱氢酶和毒素A/B的比较评估
Microorganisms. 2022 Apr 30;10(5):947. doi: 10.3390/microorganisms10050947.
2
Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).艰难梭菌感染的诊断和治疗建议:西班牙化疗学会(SEQ)、西班牙内科学会(SEMI)和西班牙麻醉与复苏学会术后感染工作组(SEDAR)的官方临床实践指南。
Rev Esp Quimioter. 2020 Apr;33(2):151-175. doi: 10.37201/req/2065.2020. Epub 2020 Feb 20.
3
A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of () in Adults.一项关于核酸扩增检测(NAATs)和包括 NAATs 在内的算法在诊断成人()中的实验室医学最佳实践系统评价和荟萃分析。
Clin Microbiol Rev. 2019 May 29;32(3). doi: 10.1128/CMR.00032-18. Print 2019 Jun 19.
4
2019 update of the WSES guidelines for management of () infection in surgical patients.2019 年 WSES 外科患者()感染管理指南更新。
World J Emerg Surg. 2019 Feb 28;14:8. doi: 10.1186/s13017-019-0228-3. eCollection 2019.
5
[Clostridium difficile infections in geriatric patients].老年患者艰难梭菌感染
Z Gerontol Geriatr. 2016 Dec;49(8):743-761. doi: 10.1007/s00391-016-1143-9. Epub 2016 Oct 26.
6
Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.对Xpert艰难梭菌检测试剂盒、BD MAX艰难梭菌检测系统、用于雅培m2000的IMDx艰难梭菌检测试剂盒以及Illumigene艰难梭菌检测试剂盒在粪便标本中直接检测产毒艰难梭菌的评估。
Ann Lab Med. 2016 Mar;36(2):131-7. doi: 10.3343/alm.2016.36.2.131.
7
WSES guidelines for management of Clostridium difficile infection in surgical patients.WSES外科患者艰难梭菌感染管理指南。
World J Emerg Surg. 2015 Aug 20;10:38. doi: 10.1186/s13017-015-0033-6. eCollection 2015.
8
Evaluation of a chromogenic culture medium for the detection of Clostridium difficile.用于艰难梭菌检测的显色培养基的评估
Yonsei Med J. 2014 Jul;55(4):994-8. doi: 10.3349/ymj.2014.55.4.994.
9
Combination of culture, antigen and toxin detection, and cytotoxin neutralization assay for optimal Clostridium difficile diagnostic testing.为了获得最佳的艰难梭菌诊断检测效果,可将培养物、抗原和毒素检测与细胞毒素中和测定相结合。
Can J Infect Dis Med Microbiol. 2013 Summer;24(2):89-92. doi: 10.1155/2013/934945.
10
Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.2000-2010 年 Medicare Part B 报销的实验室检测量趋势。
Arch Pathol Lab Med. 2014 Feb;138(2):189-203. doi: 10.5858/arpa.2013-0149-OA. Epub 2013 Jun 5.